Insider buying last 90 days
No open-market insider purchases were filed for TEM in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every TEM insider filing, plotted on the chart in Gekko.Open TEM in Gekko
NASDAQ: TEM
Tempus AI (TEM) Stock Analysis & Forecast
Sep 28 close
$85.08+0.07 (+0.1%)
Gekko Brief
AI summaryTempus AI receives FDA 510(k) clearance for its ECG-MR AI product, designed to detect signs of undiagnosed moderate or severe mitral regurgitation from standard 12-lead ECGs. Alongside this, TempraMed announces an expanded Latin American distribution agreement with Tempus, extending the relationship beyond Panama and adding VIVI Med to the framework. Several insider sales are also disclosed, including CEO-linked entities selling 250,000 Class A shares and the Chief Accounting Officer selling $529,650 of stock, both under existing trading arrangements.
Shares close at $85.08, up 0.1%, sitting well above both the 50-day average of $60.02 and the 200-day average of $56.30, with the 50-day above the 200-day. The stock has returned 20.4% over one month, 45.9% over three months, and 99.6% over six months, trading between a 52-week low of $40.77 and a high of $104.32. The GekkoIndex reads 45.4, placing it in the Neutral zone, while the price sits 34.9% above the Gekko Fair Value of $63.05.
The next earnings report is scheduled for 3 November, 35 days out, after the last quarter's actual EPS of -$0.04 beat the -$0.14 estimate and produced a 5.6% reaction, part of 7 beats in 8 quarters averaging a 6.5% move. In the last 30 days, 7 unusual options signals appear, with call premium of $4,450,692 against put premium of $2,740,174. Analyst coverage spans 18 firms, with 10 at buy and 8 at hold, and a consensus target of $68.56.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Tempus AI price vs fair value
Close $85.08200-day averageGekko Fair Value $63.05
Tempus AI quick facts
- Market cap
- $14.91B
- P/E ratio
- —
- Forward P/E
- —
- EPS, TTM
- −$1.55
- Revenue, TTM
- $1.43B
- Profit margin
- -17.8%
- Dividend yield
- —
- Beta
- 3.72
- Volume
- 6.23M avg 6.92M
- 1-year return
- +10.0%
- Typical daily move
- ±5.7%
- Typical 20-day move
- ±15%
- 50-day average
- $60.02
- 200-day average
- $56.30
- Next earnings
- Nov 3 after close
- Shares outstanding
- 175.4M
Tempus AI swing-trade checklist
Tempus AI scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $85.08 is above the 50-day ($60.02) and 200-day ($56.30) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
45.4, Neutral
Reading 45.4 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
34.9% above
Price is 34.9% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneysupportive
Leans bullish
Last 30 days: 7 unusual options signals.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Tempus AI stock chart and price history
Tempus AI closed at $85.08 on Sep 28, 2026, +10.0% over the past year, inside a 52-week range of $40.77 to $104.32.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +20.4%
- 3 months
- +45.9%
- 6 months
- +99.6%
- 1 year
- +10.0%
The full TEM chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open TEM in Gekko
Follow Tempus AI through every session
Put TEM on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track TEM in GekkoFree for 7 days. No credit card required.
About Tempus AI
Tempus AI builds technology for healthcare providers, connecting clinicians to laboratory diagnostics, data analytics and a broad library of multimodal patient information. Its platform links a doctor's desktop directly to testing capabilities, and the company is recognized for tools such as Hub, an application that guides physicians through next-generation sequencing tests from start to finish, and Lens, used for precision research in the life sciences.
The company's offerings extend across diagnostics, including sequencing, PCR profiling and pathology testing, along with specialized assays for tumor and blood cancer analysis, inherited conditions, and psychiatric pharmacogenomics. It also licenses de-identified clinical and molecular data through a product called Insights, models tumor behavior through Organoids, matches patients to clinical trials, and runs an AI platform called Next alongside an algorithm-based diagnostics tool named Algos. Tempus AI works with pharmaceutical and biotechnology partners such as AstraZeneca, Pathos AI, GlaxoSmithKline, Merck and Recursion Pharmaceuticals, and it collaborates with Blood Cancer United on a pediatric leukemia registry.
Founded in 2015 under the name Tempus Labs before adopting its current name in 2023, the company is based in Chicago, Illinois. Its shares are listed on the NASDAQ under the ticker TEM.
- Listed
- NASDAQ
- Sector
- Technology services
- Industry
- Packaged software
- Website
- tempus.com
Tempus AI GekkoIndex: the smart money zone
Tempus AI’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 45.4, in the Neutral zone, up 0.2 points over five sessions.
45.4Neutral
Up 0.2 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +2.8% | +19.7% | ||
| Accumulation | 193 | +3.8% | +15.4% | ||
| Neutral (current zone) | 293 | +0.7% | 0.0% | ||
| Distribution | 42 | −0.3% | −9.8% | ||
| Selling | 1 | Too few readings yet | |||
Average TEM share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the TEM price, zone by zone.Track TEM in Gekko
Is Tempus AI stock overvalued? Gekko Fair Value
Tempus AI trades 34.9% above Gekko Fair Value of $63.05, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Tempus AI shares are worth, recalculated every trading day.
$63.05
Gekko Fair Value, Sep 26, 2026
34.9% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open TEM in Gekko
Tempus AI insider and Congress trading
No open-market insider purchases were filed for Tempus AI, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in TEM were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for TEM, plotted on the chart in Gekko.Open TEM in Gekko
Buybacks
Tempus AI has been buying back its own shares.
- Bought back, quarter ended Dec 31, 2025
- $3.04M
- As a share of market cap
- 0.02%
From company filings.
Unusual options activity last 30 days
7signals, 62% of the flagged premium in calls.
Latest: Bullish flow on Sep 26, $1.57M in unusual premium.
Hedge funds and billionaires quarter ended Mar 31
0of the funds Gekko tracks hold TEM.
0added0opened0trimmed2sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Tempus AI earnings: next date and track record
Tempus AI reports on Nov 3, 2026, after the close (35 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 3, 2026
Expected after the close, 35 days away
- EPS estimate
- −$0.07
- Revenue estimate
- $409.9M
7 of 8reports beat the EPS estimate
±6.5%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | −$0.04 est −$0.14 | $382.5M est $379.7M | +5.6% |
| May 5, 2026 | −$0.13 est −$0.21 | $348.1M est $345.4M | −4.1% |
| Feb 24, 2026 | −$0.04 est −$0.04 | $367.2M est $362.6M | −6.2% |
| Nov 4, 2025 | −$0.11 est −$0.17 | $334.2M est $328.7M | −7.3% |
| Aug 8, 2025 | −$0.22 est −$0.23 | $314.6M est $297.7M | +3.5% |
| May 6, 2025 | −$0.24 est −$0.26 | $255.7M est $248.1M | +8.7% |
| Feb 24, 2025 | −$0.18 est −$0.15 | $200.7M est $248.8M | −13.2% |
| Nov 4, 2024 | −$0.25 est −$0.27 | $180.9M est $179.5M | −3.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Tempus AI stock forecast and analyst price targets
Analysts’ average 12-month price target for Tempus AI is $68.56, −19.4% from the last close, from 18 firms rating the stock in the last 90 days.
$68.56consensus 12-month target, −19.4% from the last close
Now $85.08Avg $68.56
Low $45High $80
Each firm’s latest rating in the last 90 days: 18 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | Goldman Sachs | $75 | −11.8% |
| Sep 11 | H.C. Wainwright | $66 | −22.4% |
| Sep 9 | UBS | $70 | −17.7% |
| Sep 8 | Rothschild & Co Redburn | $67 | −21.3% |
| Sep 2 | Cantor Fitzgerald | $80 | −6.0% |
0.0%average 20-day move after past Neutral readings
±5.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Tempus AI market cap and key statistics
Tempus AI’s market cap is $14.91B and revenue of $1.43B over the last twelve months.
Valuation
- Market cap
- $14.91B
- EPS, TTM
- −$1.55
- Gekko Fair Value
- $63.05
Trading
- Volume
- 6.23M
- Avg volume, 20 days
- 6.92M
- 52-week high
- $104.32
- 52-week low
- $40.77
- Shares outstanding
- 175.4M
Financials
- Revenue, TTM
- $1.43B
- Profit margin
- -17.8%
- Return on equity
- -67.4%
- Quarterly earnings growth, YoY
- 0.0%
Risk and income
- Beta
- 3.72
- Typical daily move
- ±5.7%
- Typical 20-day move
- ±15%
Tempus AI stock news this week
6 headlines about Tempus AI from the past week, newest first, each linking to the publisher.
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral RegurgitationBusiness Wire, Sep 28
- Form 144 Tempus AI For: 27 September By Investing.comInvesting.com India, Sep 27
- Tempus AI (NASDAQ:TEM) Stock: Insider Eric Lefkofsky Sells 250,000 SharesDefense World, Sep 26
- Tempus AI CEO-linked entities sell 250,000 sharesStock Titan, Sep 24
- Tempus AI Chief Accounting Officer Sells $529,650 of StockThe Motley Fool, Sep 24
- TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private PlacementNewsfile Corp, Sep 24
Tempus AI peers
Tempus AI’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.3% above |
| PLTRPalantir Technologies | Neutral | 15.7% above |
| ORCLOracle | Accumulation | 25.9% below |
| PANWPalo Alto Networks | Neutral | 16.1% above |
| CRWDCrowdStrike | Neutral | 27.2% above |
| CRMSalesforce | Neutral | 5.9% below |
A peer links to its own page where one exists.
Tempus AI stock FAQ
What is Tempus AI’s market cap?
Tempus AI’s market cap is $14.91B at the Sep 28, 2026 close of $85.08, with 175.4M shares outstanding.
What is the Tempus AI stock forecast?
The consensus analyst 12-month price target for Tempus AI is $68.56, −19.4% from the last close. Of the 18 firms that rated the stock in the last 90 days, 10 rate it a buy, 8 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Tempus AI stock overvalued or undervalued?
On Gekko’s estimate Tempus AI is overvalued: the Sep 28, 2026 close of $85.08 is 34.9% above Gekko Fair Value of $63.05. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Tempus AI report earnings next?
Tempus AI is expected to report on Nov 3, 2026, after the market closes (35 days away). Analysts expect earnings of −$0.07 per share on revenue of $409.9M. Tempus AI beat the earnings estimate in 7 of its last 8 reports, moving 6.5% on average across the report.
What is Tempus AI’s 52-week high and low?
Tempus AI’s 52-week high is $104.32 and its 52-week low is $40.77; it closed at $85.08 on Sep 28, 2026, +10.0% over the past year.
Is Tempus AI stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, smart money and earnings risk), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Tempus AI?
Gekko flagged 7 unusual options signals in Tempus AI over the last 30 days, with $4.45M of flagged premium in calls and $2.74M in puts. The latest, bullish flow, was on Sep 26, 2026 with $1.57M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Tempus AI the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.